p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: The vagaries of fixation and microwave enhancement of immunocytochemistry

Journal of Oral Pathology and Medicine

Volumn 27, Issue 9, 1998, Pages 434-440

  Allison, R T ^a   Best, Teresa ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Immunocytochemistry; Ki 67; Oral squamous cell carcinoma; P53; PCNA

Indexed keywords

EID: 0032191240     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1998.tb01981.x     Document Type: Article

References (32)

1. IGGO R, GATTER K, BARTEK J, LANE DP, HARRIS A. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-9.
2. GANNON JV, GREAVES R, IGGO R. LANE DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595-602.
3. LANE DP, BENCHIMOL S. p53: oncogene or anti-oncogene. Genes Dev 1990; 4: 1-8.
4. LEVINE AJ, MOMAND J, FINLAY CA. The p53 suppressor gene. Nature 1991; 351; 453-6.
5. WYNFORD-THOMAS D. p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992; 166: 329-30.
6. BOSARI S, RONCALLI M, VIALE G, BOSSI P, COGGI G p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Pathol 1993; 169: 425-30.
7. DEI TOS AP, DOGLIONI C, LAURINO L, BARBARESCHI M, FLETCHER CDM. P53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology 1993; 22: 45-50.
8. OGDEN GR, KIDDIE RA, LUNNY DP, LANE DP. Assessment of p53 protein expression in normal, benign and malignant oral mucosa. J Pathoal 1992; 166: 389-94.
9. LARGEY JS, MELTZER SJ, YIN J, NORRIS K, SAUK JJ, ARCHIBALD DW. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 1993; 71: 1993-7.
10. SAKAI E, TSUCHIDA N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor suppressor genes. Oncogene 1992; 7: 927-33.
11. ALLISON RT, MORGAN E, PECKITT NS. p53 expression in oral squamous cell carcinomas and lymph node micrometastases. J Dent Res 1993; 73: 716 (abstr).
12. TOSCHI L, BRAVO R. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol 1988; 107: 1623-8.
13. COLTERA MD, SKELLY M, GOWN AM. Anti-PCNA antibody PC10 yields unreliable proliferation indexes in routinely processed, deparaffinized, formalin-fixed tissue. Appl Immunohist 1993; 1: 193-200.
14. GERDES J, LEMKE H, BAISCH H, WACKER H-H, SCHWAB U, STEIN H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immmunol 1984; 133: 1710-5.
15. VALENTE G, ORECCHIA R, GANDOLFO S, et al. Can Ki-67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? J Clin Pathol 1994; 47: 109-12.
16. PEZZELLA F, MICKLEM K, TURLEY H, et al. Antibody for detecting p53 protein by immunocytochemistry in normal tissue. J Clin Pathol 1994; 47: 592-6.
17. FISHER CJ, GILLETT CE, VOJTESEK B, BARNES DM, MILLIS RR. Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. Br J Cancer 1994; 69: 26-31.
18. GOWN AM, DE WEVER N, BATTIFORA H. Microwave based antigenic unmasking. A revolutionary new technique for routine immunohistochemistry. Appl Immunohist 1993; 1: 256-66.
19. LEONG AS-Y, MILIOS J. An assessment of the efficacy of the microwave antigenretrieval procedure on a range of tissue antigens. Appl Immunohist 1993; 1: 267-74.
20. DOWELL SP, OGDEN GR. The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note. J Oral Path Med 1996; 25: 60-4.
21. ALLISON RT. Effects of processing temperature on tinctorial staining of rat tissues. J Dent Res 1997; 76: 1066 (abstr).
22. ALLISON RT, BRYANT D. Paraffin processing at a constant 45°C, including wax infiltration: effects on tinctorial staining. Biotechnic Histochem 1998; (in press).
23. MIDGLEY CA, FISHER CJ, BARTEK J, VOJTESEK B, LANE DP, BARNES BM. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 1992; 101: 183-9.
24. MCKEE PH, HOBBS C, HALL PA. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 1993; 23: 377-9.
25. JOYPAUL BV, VOJTESEK B, NEWMAN EL, et al. Enzyme-linked immunosorbent assay for p53 in gastrointestinal malignancy: comparison with immunohistochemistry. Histopathology 1993; 23: 465-70.
26. YU CC-W, WILKINSON N, BRITO MJ, BUCKLEY CH, FOX H, LEVISON DA. Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium. Histopathology 1993; 23: 367-71.
27. HALL PA, LANE DP. P53 in tumour pathology: can we trust immunohistochemistry? - revisited! J Pathol 1994; 172: 1-4.
28. BRYNE M, KOPPANG HS, LILLENG R, KJÆRHEIM A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 1992; 166: 375-81.
29. LINDEN MD, NATHANSON SD, ZARBO RJ. Evaluation of anti-p53 antibody staining Quality control and technical considerations. Appl Immunohist 1994; 2: 218-24.
30. WARNAKULASURIYA KAAS, JOHNSON NW. Association of over-expression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med 1994; 23: 246-50.
31. HALL PA, COATES PJ. Assessment of cell proliferation in pathology - what next? Histopathology 1995; 26: 105-12.
32. MILNER J. Different forms of p53 detected by monoclonal antibodies in non-dividing lymphocytes. Nature 1984; 310: 143-5.